{"id":"https://genegraph.clinicalgenome.org/r/2c7bd692-905e-4fd9-a676-982ab305f8c3v1.1","type":"EvidenceStrengthAssertion","dc:description":"*COL1A2* was first reported in relation to autosomal dominant combined Osteogenesis Imperfecta Syndrome and Ehlers-Danlos/ syndrome (OIEDS) in 1997 (Nathanson et al.). Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-2 (OIEDS2) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, osteogenesis imperfecta type II (OMIM:166210), osteogenesis imperfecta type III (OMIM:259420), osteogenesis imperfecta, type IV (OMIM:166220), Ehlers-Danlos syndrome, arthrochalasia type, 2 (OMIM:617821), Ehlers-Danlos syndrome, cardiac valvular type (OMIM:225320), and Osteoporosis, postmenopausal (OMIM:166710). The split curations have been curated separately. Fifteen variants (missense and splice site) that have been reported in 17 probands in six publications (PMIDs: 10694924, 23692737, 10982177, 11288717, 23692737) are included in this curation. The mechanism of pathogenicity is known to be loss of function due to interference with N-propeptide removal. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 10/3/22 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2c7bd692-905e-4fd9-a676-982ab305f8c3","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e8dc6fb4-069c-456d-88c0-e7837c819d9d","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e8dc6fb4-069c-456d-88c0-e7837c819d9d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e8dc6fb4-069c-456d-88c0-e7837c819d9d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T20:04:40.153Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8dc6fb4-069c-456d-88c0-e7837c819d9d_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e8dc6fb4-069c-456d-88c0-e7837c819d9d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9987f893-bd98-43ee-b4d5-aab5bd0b988a","type":"EvidenceLine","dc:description":"Upgraded points to reflect the pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2 ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9987f893-bd98-43ee-b4d5-aab5bd0b988a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31193991","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8c60a4f-63b5-4682-8f36-1b31106d870e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.3296G>A (p.Gly1099Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368225672"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/9987f893-bd98-43ee-b4d5-aab5bd0b988a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Radiographs ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9d273786-153e-4bd4-8cfb-1b40adae1bec","type":"EvidenceLine","dc:description":"Upgraded to be scored similarly to pathogenic Gly-X-Y missense variants.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d273786-153e-4bd4-8cfb-1b40adae1bec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10694924","allele":{"id":"https://genegraph.clinicalgenome.org/r/150b015d-5760-484b-be7c-21bef01548bf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.432+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162914496"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dc4b24f7-0b14-4d35-9bc3-9fcd026f385f","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc4b24f7-0b14-4d35-9bc3-9fcd026f385f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/14ed3b0f-57f3-4aa6-9292-1f332b087f72","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.326G>A (p.Gly109Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368219522"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cb6e0202-422d-4159-afec-72cd2d56ad59","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb6e0202-422d-4159-afec-72cd2d56ad59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9b9e748-b294-4f80-a7ee-8f800e5aa12b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.335G>T (p.Gly112Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368219543"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6f9cb43-01b0-4a44-b600-77a1c7c50538","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6f9cb43-01b0-4a44-b600-77a1c7c50538_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11288717","allele":{"id":"https://genegraph.clinicalgenome.org/r/567bf997-ccf3-4798-a1ee-297c5c4d381e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.3105+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213000"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e6f9cb43-01b0-4a44-b600-77a1c7c50538_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No evidence of exon skipping; the predominant gene product from the use of a cryptic donor splice site using the second and third bases of a glycine codon 17 bp upstream of the normal splice junction as the obligate GT-dinucleotide.  The last 17 bp of exon 46 were deleted and the resultant frameshift introduced a termination 3 codons downstream.\n\nNMD leads to the pro a2(I) chains to not be incorporated into triple helical molecules. \nThe proband produces a type I collagen homotrimer molecule containing three a1(I) chains instead of the normal heterotrimer with two a1(I) and one a2(I) chains. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a3d5e332-ac7e-409f-ba84-66f102237365","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3d5e332-ac7e-409f-ba84-66f102237365_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b5838d5-b792-4514-889e-7b42ae617f1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.432+4_432+7del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162914491"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/072df1e7-ec96-4dd7-8a73-5804d90a075a","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/072df1e7-ec96-4dd7-8a73-5804d90a075a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/9926ecd7-425d-46ff-978c-569845e1d9cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.133G>T (p.Gly45Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368219107"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/db8bb110-ed7a-463b-8364-d989bbc6f02d","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db8bb110-ed7a-463b-8364-d989bbc6f02d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/150b015d-5760-484b-be7c-21bef01548bf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fa00f4bf-5c76-46b3-8d77-cba8f0b38cb3","type":"EvidenceLine","dc:description":"Scored similarly to a pathogenic missense Gly-X-Y variant in COL1A2. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa00f4bf-5c76-46b3-8d77-cba8f0b38cb3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/58293775-73a5-47df-8c82-c52c8370bf16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.324+4del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139660141"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fa00f4bf-5c76-46b3-8d77-cba8f0b38cb3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Leads to In-frame skipping of exon 7","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6dda8740-9ddc-45f0-a2d9-efd1495f11ea","type":"EvidenceLine","dc:description":"Upgraded to score variant similarly to a pathogenic Gly-X-Y missense variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6dda8740-9ddc-45f0-a2d9-efd1495f11ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10982177","allele":{"id":"https://genegraph.clinicalgenome.org/r/d47dc1ba-5749-474c-ab04-de5ed1c4dddd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"nsv513787","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/17271"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8701c543-7ba6-4fbf-9335-3f0f2c0d31f1","type":"EvidenceLine","dc:description":"Upgraded to reflect the similar pathogenicity of a missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8701c543-7ba6-4fbf-9335-3f0f2c0d31f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/64a6ec6b-c3b6-4044-9ab6-f774f09e154d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.693+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580060348"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aba09ec1-cec2-4be7-82f9-253fd3f7b853","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aba09ec1-cec2-4be7-82f9-253fd3f7b853_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa43544b-6653-4b95-b218-27f9d5ccb380","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2755G>A (p.Gly919Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4347547"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4133d2c9-2ec1-4fd6-87f0-b52ef9205e11","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4133d2c9-2ec1-4fd6-87f0-b52ef9205e11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/321b62c0-1dd6-4678-9e04-c3401defc93b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.197G>A (p.Gly66Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368219227"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0626d9fe-e6a7-4a1b-b6d9-e6838ed9c440","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0626d9fe-e6a7-4a1b-b6d9-e6838ed9c440_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/08ea229d-d988-47c5-9438-19c70e34e1fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.316G>A (p.Gly106Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368219490"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e4174d7f-dcc7-4e5d-a649-d3f3b65f0c8c","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4174d7f-dcc7-4e5d-a649-d3f3b65f0c8c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/20a5259c-90d0-41a5-81b2-faae45012bc9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.587G>T (p.Gly196Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368220099"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/03510cbd-e691-47c5-bc50-216deb915c4f","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03510cbd-e691-47c5-bc50-216deb915c4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b5838d5-b792-4514-889e-7b42ae617f1a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/03510cbd-e691-47c5-bc50-216deb915c4f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In-frame skipping of exon 9","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e814b563-24c1-453e-b393-e1e271148dab","type":"EvidenceLine","dc:description":"Upgraded to reflect pathogenicity of the missense variant affecting the Gly-X-Y triple helix in COL1A2.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e814b563-24c1-453e-b393-e1e271148dab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31794058","allele":{"id":"https://genegraph.clinicalgenome.org/r/a020d6bc-b47b-4cb4-b706-a43086fa73b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.577G>A (p.Gly193Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4346716"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11}],"evidenceStrength":"Moderate","sequence":6997,"specifiedBy":"GeneValidityCriteria9","strengthScore":11,"subject":{"id":"https://genegraph.clinicalgenome.org/r/k-XWwKAXByA","type":"GeneValidityProposition","disease":"obo:MONDO_0030855","gene":"hgnc:2198","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e8dc6fb4-069c-456d-88c0-e7837c819d9d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}